Prophylactic, single-drug cardioprotection in a comparative, experimental study of doxorubicin-induced cardiomyopathy

Prophylactic, single-drug cardioprotection in a comparative, experimental study of doxorubicin-induced cardiomyopathy

Abstract Background Cardiomyopathy is a common side effect of doxorubicin (DOX) chemotherapy. Despite intensive research efforts in the field, there is still no evidence available for routine cardioprotective prophylaxis to prevent cardiotoxicity in the majority of oncological patients at low risk o...

Full description

Bibliographic Details
Main Authors: Mária Lódi, Viktor Bánhegyi, Beáta Bódi, Alexandra Gyöngyösi, Árpád Kovács, Anita Árokszállási, Nazha Hamdani, Miklós Fagyas, István Édes, Zoltán Csanádi, István Czuriga, Zoltán Kisvárday, István Lekli, Péter Bai, Attila Tóth, Zoltán Papp, Dániel Czuriga
Format: Article
Language:English
Published: BMC 2020-12-01
Series:Journal of Translational Medicine
Subjects:
Doxorubicin
Anthracycline
Cardiotoxicity
Animal model
Heart failure
Online Access:https://doi.org/10.1186/s12967-020-02564-w

Internet

https://doi.org/10.1186/s12967-020-02564-w

Similar Items